Creative Medical Technology Holdings Inc (CELZ)

Jun 16, 2025

Mergers & Acquisitions Tracker - Plastics News

Jun 16, 2025

Jun 12, 2025

Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 12, 2025

Jun 09, 2025

Roth Capital Has Negative Forecast for CELZ Q2 Earnings - Defense World

Jun 09, 2025

Jun 04, 2025

Creative Medical (CELZ) Price Target Reduced by Roth Capital | C - GuruFocus

Jun 04, 2025

Jun 04, 2025

Creative Medical (CELZ) Price Target Reduced by Roth Capital | CELZ Stock News - GuruFocus

Jun 04, 2025

May 25, 2025

Should You Be Impressed By Creative Global Technology Holdings Limited's (NASDAQ:CGTL) ROE? - Yahoo Finance

May 25, 2025

May 15, 2025

Analysts Offer Insights on Healthcare Companies: Flora Growth (FLGC), Cardinal Health (CAH) and Zevra Therapeutics (ZVRA) - The Globe and Mail

May 15, 2025

May 12, 2025

Creative Medical Technology Holdings: Initiating Coverage With A Sell Rating - Seeking Alpha

May 12, 2025

May 12, 2025

$12+ Bn Chronic Lower Back Pain Market Opportunities and - GlobeNewswire

May 12, 2025

May 09, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

May 09, 2025

May 09, 2025

Creative Medical Technology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 09, 2025

May 06, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView

May 06, 2025

May 06, 2025

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain - Barchart.com

May 06, 2025

May 02, 2025

Degenerative Disc Disease Treatment Market Size in 7MM - openPR.com

May 02, 2025

May 02, 2025

Creative Medical Technology (CELZ) Projected to Post Earnings on Friday - Defense World

May 02, 2025

Apr 30, 2025

Exosome Cell and Gene Therapy Market Deep Research with Forecast - openPR.com

Apr 30, 2025

Apr 27, 2025

Companies Like Creative Medical Technology Holdings (NASDAQ:CELZ) Are In A Position To Invest In Growth - Yahoo

Apr 27, 2025

Apr 25, 2025

Creative Science, a CIMA Animal Health Company, Acquires Astaria Global - Yahoo Finance

Apr 25, 2025

Apr 22, 2025

Creative Foam buys medical supplier AccuMed from Lear - Plastics News

Apr 22, 2025

Apr 22, 2025

Venus Shines Again, ENZ To Be Delisted, SLP, CERT On Watch - RTTNews

Apr 22, 2025

Apr 22, 2025

Head-To-Head Contrast: Atara Biotherapeutics (NASDAQ:ATRA) and Creative Medical Technology (NASDAQ:CELZ) - Defense World

Apr 22, 2025

Apr 21, 2025

Exosomes Drug Market Projected To Witness Substantial Growth, - openPR.com

Apr 21, 2025

Apr 14, 2025

Longevity Health to combine with 20/20 BioLabs in all-stock deal (XAGE:NASDAQ) - Seeking Alpha

Apr 14, 2025

Apr 10, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Apr 10, 2025

Apr 10, 2025

Exosomes Market Detailed In New Research Report 2025 | Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC - newstrail.com

Apr 10, 2025

Apr 09, 2025

CELZ stock touches 52-week low at $1.9 amid market challenges - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

CELZ stock touches 52-week low at $1.9 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 04, 2025

Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN

Apr 04, 2025

Mar 31, 2025

Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews

Mar 31, 2025

Mar 30, 2025

Reviewing MiNK Therapeutics (NASDAQ:INKT) & Creative Medical Technology (NASDAQ:CELZ) - The AM Reporter

Mar 30, 2025

Mar 30, 2025

Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World

Mar 30, 2025

Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Mar 26, 2025

Mar 26, 2025

Creative Medical Technology (CELZ) to Release Quarterly Earnings on Friday - The AM Reporter

Mar 26, 2025

Mar 25, 2025

Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 25, 2025

Mar 24, 2025

What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World

Mar 24, 2025

Mar 21, 2025

Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 21, 2025

Mar 20, 2025

Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq

Mar 20, 2025

Mar 20, 2025

FDA approves expanded trial for back pain cell therapy - Investing.com India

Mar 20, 2025

Mar 20, 2025

Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener

Mar 20, 2025

Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times

Mar 20, 2025

Mar 19, 2025

Nanoparticle Drug Delivery Market Growth, Generated - openPR.com

Mar 19, 2025

Mar 18, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 18, 2025

Mar 16, 2025

Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD

Mar 16, 2025

Mar 16, 2025

Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD

Mar 16, 2025